Anti-cancer efficiency of natural killer cells differentiated from human adipose tissue-derived mesenchymal stem cells and transfected with miRNA150

Simple item page
dc.contributor.authorKarlitepe A.
dc.contributor.authorKabadayi H.
dc.contributor.authorVatansever S.
dc.contributor.authorGurdal M.
dc.contributor.authorGunduz C.
dc.contributor.authorErcan G.
dc.date.accessioned2025-04-10T11:08:29Z
dc.date.available2025-04-10T11:08:29Z
dc.date.issued2017
dc.description.abstractAim: The aim of this study is to investigate the effects of miR150 transfection on NK-like cells differentiated from adipose tissue derived mesenchymal stem cells (AD-MSCs). Methods: NK-like cells were differentiated from AD-MSCs and activated by miR150 transfection. Transfected/non-Transfected NK-like cells were characterized by immunohistochemical and RTPCR analyzes. Apoptotic efficiency of the transfected/non-Transfected NK-like cells on pancreatic cancer cells PANC1 were determined by TUNEL and RT-PCR. Results: In miR150-Transfected cells, the increased expression of NK cell-specific genes such as GKMB, KIR2DL2, CD16, CD56, NKG2D, NKp46 and increased immunoreactivity of NK cell-specific surface marker CD314 (NKG2D) were evident. TUNEL assays showed that NK-like cells with/without transfection induced apoptosis in PANC1 cells in the same manner. The decrease in oncogene expression and the increase in the tumor suppressor gene expression in PANC1 cells upon co-culture with NK-like cells differentiated from AD-MSCs were more prominent following miRNA150 transfection. Conclusion: It was shown in vitro that NK-like cells could be obtained by differentiation from AD-MSCs and their efficiency could be increased via miR150 transfection. The results are encouraging for further clinical studies in improvement of immunotherapeutic approaches for cancer therapy. Copyright © Experimental Oncology, 2017.
dc.identifier.DOI-ID10.31768/2312-8852.2017.39(3):212-218
dc.identifier.urihttp://hdl.handle.net/20.500.14701/48092
dc.publisherMorion LLC
dc.titleAnti-cancer efficiency of natural killer cells differentiated from human adipose tissue-derived mesenchymal stem cells and transfected with miRNA150
dc.typeArticle

Files

Collections

Scopus Koleksiyonu